Nutex Health 8-K: Officer Changes & Compensation Reported

Ticker: NUTX · Form: 8-K · Filed: Feb 29, 2024 · CIK: 1479681

Sentiment: neutral

Topics: executive-changes, compensation, corporate-governance

TL;DR

**Nutex Health just filed an 8-K about changes in its leadership and executive pay, so keep an eye out for potential shifts in company strategy.**

AI Summary

Nutex Health, Inc. filed an 8-K on February 29, 2024, reporting on the departure or election of directors and certain officers, as well as compensatory arrangements for officers. The filing also included information on financial statements and exhibits. The company, based in Houston, Texas, with a business address at 6030 S. Rice Ave, Suite C, has a CIK of 0001479681 and a fiscal year end of December 31.

Why It Matters

Changes in executive leadership and compensation structures can significantly impact a company's strategic direction and financial performance, influencing investor confidence.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future company direction and stability.

Key Players & Entities

FAQ

What was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on February 29, 2024.

What items were reported in this 8-K filing by Nutex Health, Inc.?

The 8-K reported on the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' and 'Financial Statements and Exhibits'.

What is the business address of Nutex Health, Inc.?

The business address of Nutex Health, Inc. is 6030 S. Rice Ave, Suite C, Houston, Texas, 77081.

What is the Central Index Key (CIK) for Nutex Health, Inc.?

The Central Index Key (CIK) for Nutex Health, Inc. is 0001479681.

What was the former name of Nutex Health, Inc. before November 13, 2019?

Before November 13, 2019, Nutex Health, Inc. was formerly known as Clinigence Holdings, Inc.

Filing Stats: 734 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2024-02-29 16:37:07

Key Financial Figures

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: February 29, 2024 Nutex Health Inc. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing